QA: Atreca Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001532346_2023_Atreca_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001532346, Atreca Inc

  xvar xval
0 AssetsCurrent 78,026,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 37,972,000
3 remainder_Assets 39,032,000
4 LiabilitiesCurrent 16,293,000
5 LiabilitiesNoncurrent 60,331,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 31,028,116
9 ResearchAndDevelopmentExpense 65,546,307
10 remainder_Expenses 293,642
11 remainder_Revenues 785,039
12 remainder_NetIncome 650,074
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 155,030,000
1 Liabilities 76,624,000
2 Expenses 96,868,065
3 Revenues 785,039
4 StockholdersEquity 78,406,000
5 NetIncome -95,432,952
6 ComprehensiveNetIncome -95,432,952
7 BaseVar 164,978,589
8 EconomicCapitalRatiobeforeLimitedLiability 0.652
9 EconomicCapitalRatio 2.02

Edgar->Model Mapping

Feature Distribution

Change over Time